The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Dudchenko N.G.

Russian Medical Academy of Continuous Professional Education

Vasenina E.E.

Russian Medical Academy of Continuous Professional Education

Fluctuation of cognitive functions in dementia with Lewy bodies

Authors:

Dudchenko N.G., Vasenina E.E.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(10‑2): 89‑95

DOI: 10.17116/jnevro202012010289

Read: 6220 times

Download PDF (RU)
Contact the author
Table of contents

FLUCTUATION OF COGNITIVE FUNCTIONS IN DEMENTIA WITH LEWY BODIES
FLUCTUATION OF COGNITIVE FUNCTIONS IN DEMENTIA WITH LEWY BODIES

To cite this article:

Dudchenko NG, Vasenina EE. Fluctuation of cognitive functions in dementia with Lewy bodies. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(10‑2):89‑95. (In Russ.)
https://doi.org/10.17116/jnevro202012010289

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Analysis of cognitive status in patients with different noso­logies and clinical variants of very late mani­festing schi­zophreniform psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):88-93
Vita­min B12 defi­ciency in the elde­rly and its asso­ciations with geriatric syndromes. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):41-47
Reso­lution of the expert council «Possibilities of neuroprotective therapy in patients with arte­rial hype­rtension and cognitive diso­rders». Russian Journal of Preventive Medi­cine. 2024;(11):85-93
Cognitive functions asse­ssment of elde­rly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50
Rela­tionship between stroke-associated pneumonia and long-term outcomes of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):57-61
Cardiogenic deme­ntia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):43-49
Abstract:

Fluctuations of cognitive function (FCF) is one of the core diagnostic features of dementia with Lewy bodies (DLB). However, identification, pathophysiology, management of this unusual phenomena remain poor understood. The review presents modern ideas about phenomenology, causes, systematization, clinical significance and current methods of diagnosis and treatment of FCF in patients with DLB.

Keywords:

cognitive disorders
dementia with Lewy bodies
cognitive fluctuations
cholinesterase inhibitors
memantine

Authors:

Dudchenko N.G.

Russian Medical Academy of Continuous Professional Education

Vasenina E.E.

Russian Medical Academy of Continuous Professional Education

Received:

20.08.2020

Accepted:

25.08.2020

Close metadata

References:

  1. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis A, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Walker DTZ, Yamada M, K Kosaka. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88-100.  https://doi.org/10.1212/WNL.0000000000004058
  2. Varanese S, Perfetti B, Monaco D, Thomas A, Bonanni L, Tiraboschi P, Onofrj M Fluctuating cognition and different cognitive and behavioural profiles in Parkinson’s disease with dementia: comparison of dementia with Lewy bodies and Alzheimer’s disease. J Neurol. 2010;257:1004-1011. https://doi.org/10.1007/s00415-010-5453-3
  3. Lee DR, Taylor J-P, Thomas AJ. Assessment of cognitive fluctuation in dementia: a systematic review of the literature. International Journal of Geriatric psychiatry. 2012;27:989-998.  https://doi.org/10.1002/gps.2823
  4. Jicha GA, Schmitt FA, Abner E, Nelson PT, Cooper GE, Smith CD, Markesbery W R, Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiology of Aging. 2010;31:1805-1813. https://doi.org/10.1016/j.neurobiolaging.2008.09.017
  5. Cagnin A, Busse’ C, Gardini S, Jelcic N, Guzzo C, Gnoato F, Mitolo M, Ermani M, Caffarra P. Clinical and cognitive phenotype of mild cognitive impairment evolving to dementia with lewy bodies. Dementia and Geriatric Cognitive Disorders extra. 2015;5:442-449.  https://doi.org/10.1159/000441184
  6. Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, Graff-Radford NR, Wszolek Z, Van Gerpen J, Uitti R, Pedraza O, Murray ME, Aakre J, Parisi J, Knopman DS, Petersen RC. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology. 2013;81:2032-2038. https://doi.org/10.1212/01.wnl.0000436942.55281.47
  7. Sadiq D, Whitfield T, Lee L, Stevens T, Costafreda S, Walker Z. Prodromal dementia with Lewy bodies and prodromal Alzheimer’s Disease: a comparison of the cognitive and clinical profiles. Journal of Alzheimer’s Disease. 2017;58:463-470.  https://doi.org/10.3233/JAD-161089
  8. Williams MM, Xiong C, Morris JC, Galvin JE. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease. Neuro-logy. 2006;67 1935-1941. https://doi.org/10.1212/01.wnl.0000247041.63081.98
  9. Graff-Radford J, Aakre J, Savica R, Boeve B, Kremers WK, Ferman TJ, Jones DT, Kantarci K, Knopman DS, Dickson DW, Kukull, WA, Petersen RC. Duration and pathologic correlates of Lewy body disease. JAMA Neurology. 2017;74(3):310.  https://doi.org/10.1001/jamaneurol.2016.4926
  10. Ballard CG, Aarsland D, McKeith IG, O’Brien JT, Gray A, Cormack F, Burn D, Cassidy T, Starfeldt R, Larsen JP, Brown R, Tovee M. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology. 2002;59(11):1714-1720. https://doi.org/10.1212/01.wnl.0000036908.39696.fd
  11. Chimagomedova AS, Vasenina EE, Levin OS. Diagnotic of prodromal dementia with Levy bodies. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2017;117(6):23-32.  https://doi.org/10.17116/jnevro20171176223-32
  12. https://doi.org/10.17116/jnevro201911909225  https://doi.org/10.17116/jnevro201911909225
  13. Delli Pizzi S, Franciotti R, Taylor J-P, Thomas A, Tartaro A, Onofrj M, Bonanni L. Thalamic involvement in fluctuating cognition in dementia with Lewy bodies: magnetic resonance evidences. Cerebral Cortex. 2015;25(10):3682-3689. https://doi.org/10.1093/cercor/bhu220
  14. Franciotti R, Falasca NW, Bonanni L, Anzellotti F, Maruotti V, Comani S, Thomas A, Tartaro A, Taylor JP, Onofrj M. Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison. Neurobiology of Aging. 2013;34(4):1148-1158. https://doi.org/10.1016/j.neurobiolaging.2012.09.015
  15. Pimlott SL, Piggott M, Ballard CG, McKeith IG, Perry R, Kometa S, Owens J, Wyper D, Perry E. Thalamic nicotinic receptors implicated in disturbed conscious- ness in dementia with Lewy bodies. Neurobiology of Di-sease. 2006;21(1):50-56.  https://doi.org/10.1016/j.nbd.2005.06.008
  16. Watson R, Colloby SJ, Blamire AM, Wesnes KA, Wood J, O’Brien JT. Does attentional dysfunction and thalamic atrophy predict decline in dementia with Lewy bodies? Parkinsonism & Related Disorders. 2017;45:69-74.  https://doi.org/10.1016/j.parkreldis.2017.10.006
  17. Colloby SJ, Elder GJ, Rabee R, O’Brien JT, Taylor J-P. Structural grey matter changes in the substantia innominata in Alzheimer’s disease and dementia with Lewy bodies: a DARTEL-VBM study. International Journal of Geriatric Psychiatry. 2017;32(6):615-620.  https://doi.org/10.1002/gps.4500
  18. Lippa CF, Smith TW, Perry E. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology. Journal of Neural Transmission. 1999;106(5-6):525-535.  https://doi.org/10.1007/s007020050176
  19. Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, Ota T, Asahina M, Fukushi K, Kuwabara S, Hattori T, Suhara T, Irie T. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology. 2009;73(4):273-278.  https://doi.org/10.1212/WNL.0b013e3181ab2b58
  20. Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA. Cognitive impairment, decline and fluctuations in older com- munity-dwelling subjects with Lewy bodies. Brain. 2012;135:3005-3014. https://doi.org/10.1093/brain/aws234
  21. Merdes AR, Hansen LA, Jeste D V., Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003;60(10):1586-1590. https://doi.org/10.1212/01.wnl.0000065889.42856.f2
  22. Halliday GM, Holton JL, Revesz T, Dickson DW. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathologica. 2011;122(2):187-204.  https://doi.org/10.1007/s00401-011-0852-9
  23. Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby S J, Jellinger K, Attems J. Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs be-tween clinical phenotypes. Acta Neuropathologica. 2015;129(5):729-748.  https://doi.org/10.1007/s00401-015-1406-3
  24. Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti R J, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW. The limbic and neocortical contribution of alfa-synuclein, tau, and amyloid b to disease duration in dementia with Lewy bodies. Alzheimer’s Dementia. 2018;14(3):330-339.  https://doi.org/10.1016/j.jalz.2017.09.014
  25. Bozzali M, Falini A, Cercignani M, Baglio F, Farina E, Alberoni M, Vezzulli P, Olivotto F, Mantovan, F, Shallice T, Scotti G, Canal N, Nemni R. Brain tissue damage in dementia with Lewy bodies: an in vivo diffusion tensor MRI study. Brain. 2005;128:1595-1604. https://doi.org/10.1093/brain/awh493
  26. Sarro L, Tosakulwong N, Schwarz CG, Graff-Radford J, Przybelski SA, Lesnick TG, Zuk SM, Reid RI, Raman MR, Boeve BF, Ferman TJ, Knopman DS, Comi G, Filippi M, Murray ME, Parisi JE, Dickson DW, Petersen RC, Jack CR, Kantarci K. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer’s disease. Alzheimer’s Dement. 2017;13(3):257-266.  https://doi.org/10.1016/j.jalz.2016.07.003
  27. Kronenburg A, Spliet WG, Broekman M, Robe P. Locus coeruleus syndrome as a complication of tectal surgery. BMJ Case Reports. 2015;2014-2016. https://doi.org/10.1136/bcr-2014-207018
  28. Ziebell M, Andersen BB, Pinborg LH, Knudsen GM, Stokholm J, Thomsen G, Karlsborg M, Høgh P, Mørk ML, Hasselbalch SG. Striatal dopamine transporter binding does not correlate with clinical severity in dementia with lewy bodies. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicin. 2013;54(7):1072-1076. https://doi.org/10.2967/jnumed.112.114025
  29. Shimizu S, Hirose D, Namioka N, Kanetaka H, Hirao K, Hatanaka H, Takenoshita N, Kaneko Y, Ogawa Y, Umahara T, Sakurai H, Hanyu H. Correlation between clinical symptoms and striatal DAT uptake in patients with DLB. Annals of Nuclear Medicine. 2017;31(5):390-398.  https://doi.org/10.1007/s12149-017-1166-3
  30. Iizuka T, Kameyama M. Cingulate island sign on FDG-PET is asso- ciated with medial temporal lobe atrophy in dementia with Lewy bodies. Annals of Nuclear Medicine. 2016;30(6):421-429.  https://doi.org/10.1007/s12149-016-1076-9
  31. Peraza LR, Taylor J-P, Kaiser M. Divergent brain functional network alterations in dementia with Lewy bodies and Alzheimer’s disease. Neurobiology of Aging. 2015;36(9):2458-2467. https://doi.org/10.1016/j.neurobiolaging.2015.05.015
  32. Weissman DH, Roberts KC, Visscher KM, Woldorff MG. The neural bases of momentary lapses in attention. Nature Neuroscience. 2006;9(7):971-978.  https://doi.org/10.1038/nn1727
  33. Lowther ER, O’Brien JT, Firbank MJ, Blamire AM. Lewy body compared with Alzheimer dementia is associated with decreased functional connectivity in resting state networks. Psychiatry Research. 2014;223(3):192-201.  https://doi.org/10.1016/j.pscychresns.2014.06.004
  34. Peraza LR, Kaiser M, Firbank M, Graziadio S, Bonanni L, Onofrj M, Colloby SJ, Blamire A, O’Brien J, Taylor JP. FMRI resting state networks and their association with cognitive fluctuations in dementia with Lewy bodies. Neuroimage Clinal. 2014;4:558-565.  https://doi.org/10.1016/j.nicl.2014.03.013
  35. Peraza LR, Cromarty R, Kobeleva X, Firbank MJ, Killen A, Graziadio S, Thomas AJ, O’Brien JT, Taylor JP. Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer’s disease patients. Scientific Reports. 2018;8(1):4637. https://doi.org/10.1038/s41598-018-22984-5
  36. Schumacher J, Peraza LR, Firbank MJ, Thomas AJ, Kaiser M, Gallagher P, O’Brien J T, Blamire AM, Taylor JP. Functional connectivity in dementia with Lewy bodies: a within- and between-network analysis. Human Brain Mapping. 2018;39(3):1118-1129. https://doi.org/10.1002/hbm.23901
  37. Franciotti R, Falasca NW, Bonanni L, Anzellotti F, Maruotti V, Comani S, Thomas A, Tartaro A, Taylor JP, Onofrj M. Default network is not hypoactive in dementia with fluctuating cognition: an Alzheimer disease/dementia with Lewy bodies comparison. Neurobiology of Aging. 2013;34(4):1148-1158. https://doi.org/10.1016/j.neurobiolaging.2012.09.015
  38. Schumacher J, Peraza LR, Firbank M, Thomas AJ, Kaiser M, Gallagher P, O’Brien JT, Blamire AM, Taylor J. Dynamic functional connectivity changes in dementia with Lewy bodies and Alzheimer’s disease. Neuro Image: Clinical. 2019a;22:101812. https://doi.org/10.1016/j.nicl.2019.101812
  39. Weissman DH, Roberts KC, Visscher KM, Woldorff MG. The neural bases of momentary lapses in attention. Nature Neuroscice. 2006;9(7):971-978.  https://doi.org/10.1038/nn1727
  40. Sauer J, Ffytche DH, Ballard CG, Brown RG, Howard R. Differences between Alzheimer’s disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. Brain. 2006;129:1780-1788. https://doi.org/10.1093/brain/awl102
  41. Firbank MJ, Kobeleva X, Cherry G, Killen A, Gallagher P, Burn DJ, Thomas AJ, O’Brien JT, Taylor JP. Neural correlates of attention-executive dysfunction in lewy body dementia and Alzheimer’s disease. Human Brain Mapping. 2016;37(3):1254-1270. https://doi.org/10.1002/hbm.23100
  42. Chabran E, Roquet D, Gounot D, Sourty M, Armspach JP, Blanc F. Functional disconnectivity during inter-task resting state in Dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders. 2018;45(1-2):105-120.  https://doi.org/10.1159/000486780
  43. Taylor J-P, Colloby SJ, McKeith IG, O’Brien JT. Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodies. International Psychogeriatrics. 2013;25(12):1917-1928. https://doi.org/10.1017/S1041610213001488
  44. Bonanni L, Thomas A, Tiraboschi P, Perfetti B, Varanese S, Onofrj M. EEG comparisons in early Alzheimer’s disease, dementia with Lewy bodies and Parkinson’s disease with dementia patients with a 2-year follow-up. Brain. 2008;131:690-705.  https://doi.org/10.1093/brain/awm322
  45. Van de Ville, D., Britz, J., & Michel, C. M. (2010). EEG microstate sequences in healthy humans at rest reveal scale-free dynamics. Proceedings of the National Academy of Sciences. 107(42):18179-18184. https://doi.org/10.1073/pnas.1007841107
  46. Schumacher J, Peraza LR, Firbank MJ, Thomas AJ, Kaiser M, Gallagher P, O’Brien JT, Blamire AM, Taylor JP. Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain. 2019b;142(6):1767-1782. https://doi.org/10.1093/brain/awz069
  47. Van Dyk K, Towns S, Tatarina O, Yeung P, Dorrejo J, Zahodne LB, Stern Y. Assessing fluctuating cognition in dementia diagnosis: interrater reliability of the clinician assessment of fluctuation. American journal of Alzheimer’s Disease and Other Dementias. 2016;31(2):137-143.  https://doi.org/10.1177/1533317515603359
  48. Bradshaw J, Saling M, Hopwood M, Anderson V, Brodtmann A. Fluctuating cognition in dementia with Lewy bodies and Alzheimer’s disease is qualitatively distinct. Journal of Neurology, Neurosurgery, and Psychiatry. 2004;75(3):382-387.  https://doi.org/10.1136/jnnp.2002.002576
  49. Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D, Graff-Radford N, Parisi J,Dickson DW. DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62(2):181-187.  https://doi.org/10.1212/wnl.62.2.181
  50. Walker MP, Ayre GA, Cummings JL, Wesnes KA, McKeith IG, O’Brien JT, Ballard C G. The clinician assessment of fluctuation and the one day fluctuation assessment scale: two methods to assess fluctuating confusion in dementia. The British Journal of Psychiatry: the Journal of Mental Science. 2000a;177:252-256.  https://doi.org/10.1192/bjp.177.3.252
  51. Ballard CG, Walker M, O’Brien JT, Rowan E, McKeith IG. The char-acterisation and impact of ‘fluctuating’ cognition in dementia with Lewy bodies and Alzheimer’s disease. International Journal of Geriatric Psychiatry. 2001;16(5):494-498.  https://doi.org/10.1002/gps.368
  52. Escandon A, Al-Hammadi N, Galvin JE. Effect of cognitive fluctuation on neuropsychological performance in aging and dementia. Neurology. 2010;74(3):210-217.  https://doi.org/10.1212/WNL.0b013e3181ca017d
  53. Lee DR, McKeith IG, Mosimann U, Ghosh-Nodial A, Grayson L, Wilson B, Thomas AJ. The dementia cognitive fluctuation scale, a new psychometric test for clinicians to identify cognitive fluctuations in people with dementia. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry. 2014;22(9):926-935.  https://doi.org/10.1016/j.jagp.2013.01.072
  54. Cagnin A, Fragiacomo F, Camporese G, Turco M, Busse` C, Ermani M, Montagnese S. Sleep-wake profile in dementia with Lewy bodies, Alzheimer’s disease, and normal aging. J Alzheimer’s Dis. 2016;55:1529-1536. https://doi.org/10.3233/JAD-160385
  55. Terzaghi M, Arnaldi D, Rizzetti MC, Minafra B, Cremascoli R, Rustioni V, et al. Analysis of video-polysomnographic sleep findings in dementia with Lewy bodies. Movement Disorders: Official Journal of the Movement Disorder Society. 2013;28(10):1416-1423. https://doi.org/10.1002/mds.25523
  56. Bliwise DL, Scullin MK, Trotti LM. Fluctuations in cognition and alertness vary independently in dementia with Lewy bodies. Movement Disorders: Official Journal of the Movement Disorder Society. 2014;29(1):83-89.  https://doi.org/10.1002/mds.25707
  57. Shulman KI, Hull IM, Dekoven S, Amodeo S, Mainland BJ, Herrmann N. Cognitive fluctuations and the lucid interval in dementia: implications for testamentary capacity. J Am Acad Psychiatry Law. 2015;43:287-292. 
  58. Trachsel M, Hermann H, Biller-Andorno N. Cognitive fluctuations as a challenge for the assessment of decision-making capacity in patients with dementia. American Journal of Alzheimer’s Disease and Other Dementias. 2015;30:360-363.  https://doi.org/10.1177/1533317514539377
  59. Stinton C, McKeith IG, Taylor J-P, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O’Brien JT. Pharmacological management of Lewy body dementia: a sys- tematic review and meta-analysis. The American Journal of Psychiatry. 2015;172(8):731-742.  https://doi.org/10.1176/appi.ajp.2015.14121582
  60. Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S. Efficacy and safety of galantamine in patients with dementia with lewy bodies: a 24-week open-label study. Dementia and Geriatric Cognitive Disorders. 2007;23(6):401-405.  https://doi.org/10.1159/000101512
  61. Kazui H, Adachi H, Kanemoto H, Yoshiyama K, Wada T, Tokumasu Nomura K, Tanaka T, Ikeda M. Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: an open-label study with actigraphy. Psychiatry Research. 2017;251:312-318.  https://doi.org/10.1016/j.psychres.2017.02.039
  62. Stinton C, McKeith IG, Taylor J-P, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O’Brien, Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. American Journal of Psychiatry. 2015;172(8):731-742.  https://doi.org/10.1176/appi.ajp.2015.14121582
  63. Levin OS, Vasenina EE, Anikina MA, Makotrova TA. Dementia with Lewy bodies. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. Specvypuski. 2012;112(10):3-12. (In Russ.).
  64. Freund H-J, Kuhn J, Lenartz D, Mai J, Schnell T, Klosterkoetter J, Sturm V. Cognitive functions in a patient with Parkinson-dementia syn- drome undergoing deep-brain stimulation. Archives of Neurology. 2009;66(6):781-785.  https://doi.org/10.1001/archneurol.2009.102
  65. Gratwicke J, Zrinzo L, Kahan J, Peters A, Beigi M, Akram H, Hyam J, Oswal A, Day B, Mancini L, Thornton J, Yousry T, Limousin P, Hariz M, Jahanshahi M, Foltynie T. Bilateral deep brain stimulation of the nucleus basalis of meynert for Parkinson disease dementia a randomized clinical trial. JAMA Neurology. 2018;75(2):169-178.  https://doi.org/10.1001/jamaneurol.2017.3762
  66. Varanese S, Perfetti B, Gilbert-Wolf R, Thomas A, Onofrj M, Di Rocco A. Modafinil and armodafinil improve attention and global mental status in Lewy bodies disorders: preliminary evidence. International Journal of Geriatric Psychiatry. 2013;28(10):1095-1097. https://doi.org/10.1002/gps.3952
  67. Lapid MI, Kuntz KM, Mason SS, Aakre JA, Lundt ES, Kremers, Allen LA, Drubach DA, Boeve BF. Efficacy, safety, and tolerability of armodafinil therapy for hypersomnia associated with dementia with lewy bodies: a pilot study. Dementia and Geriatric Cognitive Disorders. 2017;43(5-6):269-280.  https://doi.org/10.1159/000471507
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.